Vaccination and Screening for the Prevention of Cervical Cancer: Health Effects and Cost-effectiveness
(Vaccinatie en screening voor de preventie van baarmoederhalskanker: Gezondheidseffecten en kosteneffectiviteit)
2011-02-16
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(110216_Kok. Inge Martina Cornelia Maria de.pdf, 2.5MB) |
|
View PDF Version
(stellingen.pdf, 0.0MB) |
Repository contains one additional file which is not publicly available
Cancer of the cervix uteri is the third most common cancer among women worldwide. The incidence and mortality in the Netherlands, however, are very low, partly because of an effective screening programme. Next to the well-known conventional Pap smear, other medical interventions are available and have been developed more recently to prevent death from cervical cancer. This is, amongst others, liquid-based cytology, HPV DNA screening, and HPV vaccination. This thesis presents health effects and cost-effectiveness of cervical cancer screening and HPV vaccination, in the Netherlands as well as internationally.
Supervisor
(promotor):
The
author
wishes to thank:
Erasmus MC Rotterdam
Keywords
Automatically Extracted Terms
- cancer
- screening
- vaccination
- cost-effectiveness
- women
- health
- incidence
- netherland
- health care costs
- hpv vaccination
- effect
- life years
- cost-effectiveness ratio
- mortality
- vaccine
- increase
- cancer screening
- ratio
- death
- trend
